IP Library Granted Patent US 12,016,879
Granted Patent B2
US 12,016,879 · App. 16/171,678 · Granted Jun 25, 2024

Calcium electroporation delivery apparatus and method

Inventors: Sarah M. Gruba (Vadnais Heights, MN); Douglas D. Pagoria (Forest Lake, MN); James P. Rohl (Prescott, WI); Stephen J. Hahn (Shoreview, MN); Suraj Kapa (Rochester, MN); Chance M. Witt (Rochester, MN)
Assignees: Boston Scientific Seimed, Inc.; Mayo Foundation For Medical Education And Research
A61K33/06A61B18/1492A61K9/0009A61K33/14A61K33/42A61B2018/0022A61B2018/00238A61B2018/00351A61B2018/00577A61B2018/00613A61B2018/00839
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,016,879
App. No.
16/171,678
Granted
Jun 25, 2024
Kind
B2
Abstract

In various aspects, the present disclosure provides methods for applying ablation therapy to a target tissue region within a patient, which methods include: (a) navigating a catheter to a target tissue region within the patient, the catheter including an elongate body having a proximal portion and a distal portion and a balloon structure positioned at the distal portion of the elongate body, which balloon structure may be permeable to a calcium-ion-containing solution that comprises one or more calcium salts; (b) positioning the balloon structure at the target tissue region; (c) delivering energy to the target tissue region; and (d) eluting the calcium-ion-containing solution from the balloon structure before, during, and/or after delivering the energy to the target tissue region. In various other aspects, the present disclosure provides apparatuses that can be used for performing such methods, among others.

Claims (12)

1. A method for applying ablation therapy to a target tissue region within a patient's heart, the method comprising:

navigating a catheter to the target tissue region within the patient's heart, the catheter including an elongate body having a proximal portion and a distal portion and a balloon structure positioned at the distal portion of the elongate body, the balloon structure comprising a porous region that is permeable to a calcium-ion-containing solution that comprises one or more calcium salts, and a nonporous region;

anchoring the nonporous region of the balloon structure at the target tissue region of the patient's heart;

positioning the porous region of the balloon structure adjacent the target tissue region;

delivering energy to the target tissue region of the patient's heart; and

eluting the calcium-ion-containing solution from the balloon structure before, during, and/or after delivering the energy to the target tissue region of the patient's heart to create areas of irreversible electroporation.

2. The method of claim 1 , comprising eluting the calcium-ion-containing solution during delivery of the energy to the target tissue region.

3. The method of claim 1 , comprising eluting the calcium-ion-containing solution after delivery of the energy to the target tissue region.

4. The method of claim 1 , comprising eluting a solution containing a Group IA metal halide salt from the balloon structure before and/or during delivery of the energy to the target tissue region, and eluting the calcium-ion-containing solution after delivery of the energy to the target tissue region.

5. The method of claim 1 , wherein eluting a calcium-ion containing solution comprises eluting a concentration of calcium ions in the calcium-ion-containing solution of at least 250 nM.

6. The method of claim 1 , wherein eluting a calcium-ion containing solution comprises eluting a concentration of calcium ions in the calcium-ion-containing solution ranging from 250 nM to 500 mM.

7. The method of claim 1 , wherein eluting a calcium-ion containing solution comprises eluting a calcium-ion-containing solution comprising one or more calcium salts selected from the group consisting of: calcium halide salts, calcium salts of organic acids, calcium phosphate, calcium chloride, and combinations thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2023
From: ROHL, JAMES P.; GRUBA, SARAH M.; HAHN, STEPHEN J.; PAGORIA, DOUGLAS D.; KAPA, SURAJ; WITT, CHANCE M.
To: BOSTON SCIENTIFIC SCIMED, INC.; MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Reel/Frame 063129/0940 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 30, 2018
From: GRUBA, SARAH M.; PAGORIA, DOUGLAS D.; ROHL, JAMES P.; HAHN, STEPHEN J.
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 047354/0764 →
Continuity (2)
Provisional Application 62577824 · Oct 27, 2017
Related Publication 20190125788A1 · May 2, 2019